Compounding pharmacy and IBD 50 newcomer Hims & Hers Health reported bullish earnings and sales growth late Monday. But Hims ...
Around the world, progressive parties have come to see tight immigration restrictions as unnecessary, even cruel. What if ...
As the Trump administration moves to freeze foreign aid, halting vital humanitarian health programmes and medical research ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
Jean-Laurent Casanova's journey began in Paris, where he simultaneously studied medicine and biology, tailoring his own MD ...
In 2023 the United States Court of Appeals for the Federal Circuit issued a precedential ruling in favor of SNIPR in a CRISPR patent interference case with Rockefeller University, thereby upholding ...
The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug ...
Novo Nordisk A/S was the biggest leader among large stocks during the session, gaining 5.8%, and DNO ASA gained 5.4%. Carlsberg A/S Series A rounded out the top three leaders on Friday, with shares ...
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Approval Drop. In this article, we ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...
Mexico, China and Canada were the largest importers for the US in 2023, and the first targets of US President Donald Trump’s ...